More recently, several brain tumor types including IDH-mutant gliomas have been found to be sensitive to inhibitors of dihydroorotate dehydrogenase (DHODH), an enzyme in the de novo pyrimidine synthesis pathway53,85,86. This evidence concerns the gene IDH1 and brain neoplasm.